GENE ONLINE|News &
Opinion
Blog

2021-11-21|

The Era of Enzymatic DNA Synthesis: How Can DNA Printing Be Useful for Research?

by Ameya Paleja
Share To
If you were involved in molecular biology research at the turn of the millennium, you would remember how painful it was to determine the effect of changes in DNA sequence in your gene of interest. Not only did you have to carry out lengthy assays, but you also needed to first make those changes happen yourself.

DNA printing is the branch of synthetic biology that deals with manufacturing DNA molecules on a large scale. In the past, manufacturing has relied on bacterial fermentation systems that are long drawn out processes and even require the use of antibiotic resistance genes to select the right bacteria in the mix. The method generates a significant amount of waste and is also time-intensive since there are a series of steps needed to isolate the molecule of interest from the biological machinery that makes it.

Chemical-based synthesis has another disadvantage. The process of manufacturing uses toxic chemicals that need to be dealt with appropriately and by waste management experts. Apart from administrative headaches, these chemicals are also not eco-friendly. So, even though they may be off your site, they are still polluting somewhere else. This has prompted biotech entrepreneurs to look for more innovative ways to synthesize DNA without having to deal with toxic chemicals but also speed up custom DNA production. 

GO Prime with only $1.49 now

LATEST
23andMe Files for Bankruptcy, DNA Data of 15 Million Users at Risk
2025-03-25
Psychedelics Inching Forward – Psilocybin Therapy Shows Sustained Benefits for Treatment-Resistant Depression
2025-03-24
Healthcare Through the Eyes of AI: Coding the Future of Medicine Through Digital Acceleration
2025-03-21
European Pharmaceutical Review Highlights RNA Therapeutics and Process Analytical Technology in 2025 Issue 1
2025-03-21
Study Examines Long-Term Effects of Anti-Amyloid Drug for Rare Alzheimer’s Variant
2025-03-21
Sanofi Acquires Bispecific Drug Candidate in $600 Million Deal Focused on Autoimmune Disorders
2025-03-21
Trump Administration Policies May Impact Health Care for Intersex Individuals
2025-03-21
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
Scroll to Top